Ye-Seul Lee , Soo Jin Kim , Kyung Sun Park , Yoon Jae Lee , Changsop Yang , Chang-Hyun Han , In-Hyuk Ha
{"title":"药物穿刺与物理疗法治疗慢性腰痛的成本-效用分析:一项多中心、实用的随机对照试验","authors":"Ye-Seul Lee , Soo Jin Kim , Kyung Sun Park , Yoon Jae Lee , Changsop Yang , Chang-Hyun Han , In-Hyuk Ha","doi":"10.1016/j.imr.2025.101210","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Chronic low back pain (cLBP) is a significant global health issue, contributing to disability and economic strain. Nonpharmacological treatments, such as acupuncture and integrative approaches like pharmacopuncture (PPT), have shown potential in alleviating the burden of cLBP. This study aimed to evaluate the cost-effectiveness of PPT compared to physical therapy (PT) for managing cLBP from both healthcare system and societal perspectives.</div></div><div><h3>Methods</h3><div>A multicenter, two-arm randomized controlled trial was conducted, involving 100 patients with cLBP. Patients were randomized into either the PPT group or the PT group, receiving 10 treatment sessions over five weeks. Utility was measured using the EuroQol 5-Dimension 5-Level scale (EQ-5D-5L) to calculate quality-adjusted life years (QALYs), and costs were evaluated from healthcare and societal perspectives, including medical costs and productivity loss. Productivity loss was assessed using the Work Productivity and Activity Impairment (WPAI) questionnaire. Incremental cost-effectiveness ratios (ICERs) were calculated by dividing the differences in costs by the differences in QALYs between the two groups. Bootstrapping and sensitivity analyses were performed to assess robustness.</div></div><div><h3>Results</h3><div>PPT was more cost-effective than PT, particularly from a societal perspective where it demonstrated lower overall costs and improved QALY. From a healthcare system perspective, the ICER of PPT was 16,575 USD per QALY, indicating cost-effectiveness. Sensitivity analyses confirmed the robustness of these findings.</div></div><div><h3>Conclusion</h3><div>This study highlights PPT as a potentially cost-effective alternative to conventional PT for cLBP, though further research with larger sample sizes and extended follow-up is recommended to validate these results.</div></div><div><h3>Trial registration</h3><div>ClinicalTrials.gov (NCT04833309), Clinical Research Information Service (KCT0006088).</div></div>","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":"14 4","pages":"Article 101210"},"PeriodicalIF":3.0000,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A cost-utility analysis of pharmacopuncture versus physiotherapy for chronic low back pain: A multicenter, pragmatic randomized controlled trial\",\"authors\":\"Ye-Seul Lee , Soo Jin Kim , Kyung Sun Park , Yoon Jae Lee , Changsop Yang , Chang-Hyun Han , In-Hyuk Ha\",\"doi\":\"10.1016/j.imr.2025.101210\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Chronic low back pain (cLBP) is a significant global health issue, contributing to disability and economic strain. Nonpharmacological treatments, such as acupuncture and integrative approaches like pharmacopuncture (PPT), have shown potential in alleviating the burden of cLBP. This study aimed to evaluate the cost-effectiveness of PPT compared to physical therapy (PT) for managing cLBP from both healthcare system and societal perspectives.</div></div><div><h3>Methods</h3><div>A multicenter, two-arm randomized controlled trial was conducted, involving 100 patients with cLBP. Patients were randomized into either the PPT group or the PT group, receiving 10 treatment sessions over five weeks. Utility was measured using the EuroQol 5-Dimension 5-Level scale (EQ-5D-5L) to calculate quality-adjusted life years (QALYs), and costs were evaluated from healthcare and societal perspectives, including medical costs and productivity loss. Productivity loss was assessed using the Work Productivity and Activity Impairment (WPAI) questionnaire. Incremental cost-effectiveness ratios (ICERs) were calculated by dividing the differences in costs by the differences in QALYs between the two groups. Bootstrapping and sensitivity analyses were performed to assess robustness.</div></div><div><h3>Results</h3><div>PPT was more cost-effective than PT, particularly from a societal perspective where it demonstrated lower overall costs and improved QALY. From a healthcare system perspective, the ICER of PPT was 16,575 USD per QALY, indicating cost-effectiveness. Sensitivity analyses confirmed the robustness of these findings.</div></div><div><h3>Conclusion</h3><div>This study highlights PPT as a potentially cost-effective alternative to conventional PT for cLBP, though further research with larger sample sizes and extended follow-up is recommended to validate these results.</div></div><div><h3>Trial registration</h3><div>ClinicalTrials.gov (NCT04833309), Clinical Research Information Service (KCT0006088).</div></div>\",\"PeriodicalId\":13644,\"journal\":{\"name\":\"Integrative Medicine Research\",\"volume\":\"14 4\",\"pages\":\"Article 101210\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-08-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Integrative Medicine Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2213422025000903\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"INTEGRATIVE & COMPLEMENTARY MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Integrative Medicine Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213422025000903","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
A cost-utility analysis of pharmacopuncture versus physiotherapy for chronic low back pain: A multicenter, pragmatic randomized controlled trial
Background
Chronic low back pain (cLBP) is a significant global health issue, contributing to disability and economic strain. Nonpharmacological treatments, such as acupuncture and integrative approaches like pharmacopuncture (PPT), have shown potential in alleviating the burden of cLBP. This study aimed to evaluate the cost-effectiveness of PPT compared to physical therapy (PT) for managing cLBP from both healthcare system and societal perspectives.
Methods
A multicenter, two-arm randomized controlled trial was conducted, involving 100 patients with cLBP. Patients were randomized into either the PPT group or the PT group, receiving 10 treatment sessions over five weeks. Utility was measured using the EuroQol 5-Dimension 5-Level scale (EQ-5D-5L) to calculate quality-adjusted life years (QALYs), and costs were evaluated from healthcare and societal perspectives, including medical costs and productivity loss. Productivity loss was assessed using the Work Productivity and Activity Impairment (WPAI) questionnaire. Incremental cost-effectiveness ratios (ICERs) were calculated by dividing the differences in costs by the differences in QALYs between the two groups. Bootstrapping and sensitivity analyses were performed to assess robustness.
Results
PPT was more cost-effective than PT, particularly from a societal perspective where it demonstrated lower overall costs and improved QALY. From a healthcare system perspective, the ICER of PPT was 16,575 USD per QALY, indicating cost-effectiveness. Sensitivity analyses confirmed the robustness of these findings.
Conclusion
This study highlights PPT as a potentially cost-effective alternative to conventional PT for cLBP, though further research with larger sample sizes and extended follow-up is recommended to validate these results.
Trial registration
ClinicalTrials.gov (NCT04833309), Clinical Research Information Service (KCT0006088).
期刊介绍:
Integrative Medicine Research (IMR) is a quarterly, peer-reviewed journal focused on scientific research for integrative medicine including traditional medicine (emphasis on acupuncture and herbal medicine), complementary and alternative medicine, and systems medicine. The journal includes papers on basic research, clinical research, methodology, theory, computational analysis and modelling, topical reviews, medical history, education and policy based on physiology, pathology, diagnosis and the systems approach in the field of integrative medicine.